fingolimod hydrochloride has been researched along with Protein Aggregation, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francolini, M; Joshi, P; Mastrangelo, R; Matteoli, M; Ruiz, A; Verderio, C | 1 |
| Beeg, M; Boda, E; Braida, D; Buffo, A; Gabrielli, M; Gardoni, F; Gobbi, M; Joshi, P; Marcello, E; Matteoli, M; Mazzitelli, S; Pelucchi, S; Ponzoni, L; Sala, M; Stravalaci, M; Verderio, C | 1 |
2 other study(ies) available for fingolimod hydrochloride and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Testing Aβ toxicity on primary CNS cultures using drug-screening microfluidic chips.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Dimethylpolysiloxanes; Embryo, Mammalian; Equipment Design; Fingolimod Hydrochloride; High-Throughput Screening Assays; Hippocampus; Microfluidic Analytical Techniques; Microglia; Neurons; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Printing, Three-Dimensional; Propylene Glycols; Protein Aggregation, Pathological; Rats; Shear Strength; Sphingosine; Surface Properties | 2014 |
Fingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal Neurons.
Topics: Amyloid; Amyloid beta-Peptides; Animals; Calcium; Cell Membrane; Fingolimod Hydrochloride; Memory; Mice; Mice, Transgenic; Neuroprotective Agents; Protein Aggregates; Protein Aggregation, Pathological; Protein Binding; Pyramidal Cells; Receptors, N-Methyl-D-Aspartate; Synapses | 2017 |